Turan Alparslan, Karamanlioğlu Beyhan, Memiş Dilek, Hamamcioglu Mustafa Kemal, Tükenmez Barş, Pamukçu Zafer, Kurt Imran
Trakya University Medical Faculty, Department of Anaesthesiology, Edirne,Turkey.
Anesthesiology. 2004 Apr;100(4):935-8. doi: 10.1097/00000542-200404000-00025.
A combination of opioid and nonopioid analgesic drugs may improve the quality of postoperative analgesia as well as reduce opioid requirements and their associated side effects. Studies have shown synergism between gabapentin and morphine in animal and human experiments and in the treatment of incisional pain. Therefore, the authors investigated, in a randomized, placebo-controlled, double-blind study, the effects of gabapentin on acute postoperative pain and morphine consumption in patients undergoing spinal surgery.
After standard premedication, 25 patients in the control group received oral placebo, and 25 patients in the gabapentin group received 1,200 mg of gabapentin, 1 h before surgery in a randomized fashion. Anesthesia was induced with propofol and cisatracurium and was maintained with sevoflurane and remifentanil. The total intraoperative remifentanil consumption by each patient was noted. All patients postoperatively received patient-controlled analgesia with morphine (1 mg/ml) with an incremental dose of 2 mg, a lockout interval of 10 min, and a 4-h limit of 40 mg. The incremental dose was increased to 3 mg, and the 4-h limit to 50 mg, if analgesia was inadequate after 1 h. Patients were questioned for the first 1 h in the PACU and were later evaluated in the ward at 1, 2, 4, 6, 12, and 24 h. Pain scores, heart rate, oxygen saturation measured by pulse oximetry, mean blood pressure, respiratory rate, sedation, morphine use, and total dose of morphine were recorded.
Overall, pain scores at 1, 2, and 4 h were significantly lower in the gabapentin group when compared with the placebo group. Total morphine consumption in the gabapentin group was 16.3 +/- 8.9 mg (mean +/- SD) versus 42.8 +/- 10.9 mg in the placebo patients. The incidence of vomiting and urinary retention was significantly (P < 0.05) higher in the placebo group, but there was no difference in incidence of other adverse effects between the groups.
Preoperative oral gabapentin decreased pain scores in the early postoperative period and postoperative morphine consumption in spinal surgery patients while decreasing some morphine-associated side effects.
阿片类药物与非阿片类镇痛药物联合使用可能会提高术后镇痛质量,并减少阿片类药物的用量及其相关副作用。研究表明,加巴喷丁与吗啡在动物和人体实验以及切口疼痛治疗中具有协同作用。因此,作者在一项随机、安慰剂对照、双盲研究中,调查了加巴喷丁对脊柱手术患者术后急性疼痛和吗啡用量的影响。
在标准术前用药后,25例对照组患者随机接受口服安慰剂,25例加巴喷丁组患者在手术前1小时接受1200毫克加巴喷丁。采用丙泊酚和顺式阿曲库铵诱导麻醉,并用七氟醚和瑞芬太尼维持麻醉。记录每位患者术中瑞芬太尼的总用量。所有患者术后均接受吗啡(1毫克/毫升)患者自控镇痛,增量剂量为2毫克,锁定间隔为10分钟,4小时限量为40毫克。如果1小时后镇痛效果不佳,增量剂量增加至3毫克,4小时限量增加至50毫克。患者在麻醉后恢复室(PACU)的前1小时接受询问,随后在病房1、2、4、6、12和24小时进行评估。记录疼痛评分、心率、经脉搏血氧饱和度测定的氧饱和度、平均血压、呼吸频率、镇静情况、吗啡使用量和吗啡总剂量。
总体而言,与安慰剂组相比,加巴喷丁组在1、2和4小时的疼痛评分显著更低。加巴喷丁组的吗啡总用量为16.3±8.9毫克(平均值±标准差),而安慰剂组患者为42.8±10.9毫克。安慰剂组呕吐和尿潴留的发生率显著更高(P<0.05),但两组之间其他不良反应的发生率没有差异。
术前口服加巴喷丁可降低脊柱手术患者术后早期的疼痛评分和术后吗啡用量,同时减少一些与吗啡相关的副作用。